Licenses & accreditation
The rights of GynEC®-DX belong to GEADIC Biotech AIE, whose sole shareholder is Reig Jofre.
Robust patent portfolio
GynEC®-DX has a strong patent portfolio with patents approved in the European Union, USA and China since 2015.
GynEC®-DX analysis is currently performed at Atrys Health laboratory (Barcelona). The shift towards the commercialization of test kits to other authorized laboratories is underway.
GynEC®-DX is distributed by Reig Jofre in Spain. We are looking for international partners to commercialize GynEC®-DX in the remaining part of the world.